Clinical trials for registration in the European Union: the EMEA 5-year experience in oncology-Reference-Cited by-同舟云学术

Clinical trials for registration in the European Union: the EMEA 5-year experience in oncology

Published:2002-05 Issue:2 Volume:42 Page:123-135
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Pignatti Francesco,Aronsson Bo,Vamvakas Spiros,Wade George,Papadouli Irene,Papaluca Marisa,Moulon Isabelle,Courtois Patrick Le

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference30 articles.

1. European Agency for the Evaluation of Medicinal Products. Fifth General Report 1999. EMEA 2000; http://www.emea.eu.int (accessed 10 August 2001).

2. European Agency for the Evaluation of Medicinal Products. Note for Guidance on Evaluation of Anticancer Medicinal Products in Man (CPMP/EWP/205/95). EMEA 2000; http://www.emea.eu.int (accessed 10 August 2001).

3. A new and fast drug approval system in Europe;Sauer;Drug Int. J.,1997

4. Wider perspectives of European medicines control;Jones;Drug Int. J.,1996

5. The European Agency for the evaluation of medicinal product's centralized approach to product approval: current status;Healy;Drug Int. J.,1999

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13;BMJ;2017-10-04

2. Observations on Three Endpoint Properties and Their Relationship to Regulatory Outcomes of European Oncology Marketing Applications;The Oncologist;2015-05-06

3. Approval probabilities and regulatory review patterns for anticancer drugs in the European Union;Critical Reviews in Oncology/Hematology;2013-08

4. New anti-neoplastic drug test using in vitro model: what to be concern?;DARU Journal of Pharmaceutical Sciences;2012-10-24

5. Showing Efficacy in Treating Rare Pediatric Tumors: Introduction to European Regulatory and Scientific Support Available to Investigators;Rare Tumors In Children and Adolescents;2011-10-28